amgen hasn't moved wait the others in that space have moved. and to what michael said, we're talking about a once a month injectable. that's probably a game changer. as we move towards that, it's probably going to be better than that. i would rather have the name that hasn't moved and amgen is one. >> if you look at the eighth largest holder if we have a chart, little double bottom getting traction. vertex is the largest holding in the ibb. that stock has been parabolic. trying to find stocks, i think, that haven't had to move. steve mentioned amgen and i throw qb in the mix. >> the severe underweighting towards biotech, where are you? >> i do think that it is likely going to be another category that will benefit from lower interest rates. especially it's going to have more m&a. you want to look at companies where the patent expiring is going to be a big deal for a lot of these companies so even if they are scooping up other firms, it needs more than to offset what they're losing. that's what you keep an eye on. >> we talked about pfizer. i've

i think amgen is a fine way to play it. they haven't gotten nearly the credit lilly and novo vchl could there be another $50 billion, is hundred llion dollars jump if they're as good or better? it possible. >> ipfizer worth investing? do you tnk it's a value, or do you think it's too murky at this point? it's trading terribly, doesn't have the pipeline, there are too many unknowns? >> it's been decadesince the stock really worked. it worked dung covid for obvious reasons -- >> so no. >> i not there. i find it very difficult. i think any time you have to acquire drugs, that all of you mentioned earlier in the show, in order to just fulfill revenue and earnings growth, i think that's a tough story. >> forittlely and novo, what are some of the wild cards that can stand in the stock's continued gains? is it black box label in europe because of the suicide concerns? what iit out there? >> i'm not concerned about t south s suicidsituation. seems too small to matter, and it's really refined to a select community. but i do think pr

amgen is another one, the early data looked pretty good. then you have a lot of other companies in the fray, too. astrazeneca just did a deal in asia to get their hands on an asset. you have viking therapeutics and small cap bio tech. and though the data hasn't looked perfectly clean, structure gpcr is another one. this is going to be an area with more competcompetition. lilly and novo might just lead the pack for awhile. >> lilly and knovo up 50% to date, you mentioned amgen. last time, we discussed this. how early is too early to be looking at amgen, who hasn't had the run that those other two players have had, obviously it's a much better delivery system, you said that the early trials look good. is it too early to start buying that stock now? >> not at all. i don't think so. i think a lot of investors have been adding to positions, or putting new long positions on an amgen for the past couple of months, because they kind of want to get ahead of the curve on this one. they're looking at novo and lilly and the years they've had, and if am

and that leaves amgen, i don't want amgen because that conflicts with eli lilly, i would like to ee ito see, i want to see honeywell here, because it is a cyclical stock that is still not blazing through at 52 high, you make that change and then you will be diversified. let's go to michael in california. michael? >> hello, jim. >> how are you doing? >> good, i just wanted to get your quick opinion >> sure. go ahead. do you have your portfolio? >> -- >> if you have five stocks sir? >> yes, sure, >> tesla, alto, hathaway, hawthorne and >> alto, tremendous retailer, we have berkshire hathaway, that is a conglomerate run buy warren buffett, ralph lauren is a company that is doing far better than people realize, tesla is an auto/tech company and derek is a gold company, so we have gold, retail, diversified oh, is ralph lauren the same as alto, i'm going to call this apparel, not retail and then we will be able to save it and then you can keep the gold company and keep tesla. that is apparel, not retail. let's go to doug in alabama. doug? >> hey, jim, roll tide. >> what's up, man. good, rol

three positive calls on amgen just this week. it's definitely about the companies that have stuck to their hitting, in diabetes especially, really the prime example there. let's get the opening bell on the cnbc realtime exchange. at the big board, it's sp funds. and at the nasdaq, it's a building technology company celebrating its recent ipo as we try to get back to 4,760, dow getting dinged by nike. i'm wondering whether -- how you're viewing the commentary you're getting on the half just in terms of sentiment, whether we do feel like this is over our skis, given the backdrop of earnings, at least. >> i feel like people are still bullish and maybe even getting more so and looking to areas other than mega cap to do so suggesting that if you look away from that, that the market isn't as expensive as it otherwise might appear to be. >> this is like the tom lee ex-f.a.n.g. 15 multiple that we hear about. >> if you look at the total multiple, it's 20 times, it's historically expensive. we've never been able to maintain that over a lo

you take a look at chevron, amgen, cisco, jpmorgan, and intel, those are the current dogs of the dow.ecause of the intel performance and jpmorgan performance, up in price, yields gone down, they are now going to get probably kicked out. they're going to be replaced by a couple of other stocks. a consumer staples name in coca-cola, also a health care name in johnson & johnson. both of those stocks have underperformed so far this year, and both carry a roughly 3.1% dividend yield overall. as you take a look at the dogs, sara, this time around, the list for 2024, very similar to 2023. but we're going to kick out intel because it's done so well. kick out jpmorgan, because it's done so well. we'll put in coca-cola and johnson & johnson. we'll see how that plays out. i'll send things back to you. >> some of the dividend payers making a little bit of a stand here as we're seeing these lower rates. dom, thank you very much. >>> as we head to break, it is time for the bond report. speaking of lower rates, let's take another look at how treasurys are faring this morning. yields, well, they reac

he was appointed last may after serving as vp at amgen. >>> alphabet says it will restrict the type oftions. the restrictions will be alphabet focuses on the role a. plays. >>> the irs is waiving $1 billion in fees for backes taxes from 2020 and 2021. businesses who will be eligible next week, totals $1 billion in exempt fees. >>> and tesla skips stock awards. the workers wither still given cost of-of-living increases >>> and one of our big money movier ts morning, shares of fedex under pressure after the company missed second quarter earnings estimates and lowered its revenue forecast as lower demand and surcharges weigh on their business. shares of fedex down about 10% right now. >>> optimism on wall street showing no signs of owing wn as they cheeon a potential for a santa claus rally. it's not just this year. next year could be poised for even more gains. strategists calling for the s&p 500 to break above 5,000 and beyond. that including our next guest who currently has the highest target on the street. joining me now, ed yardeni, founder of yardeni research. ed, good morning. it's

and amgen is being called a top pick, why it's up 2%. these etfs, up from 2.5 to 4% right now. so keep an eye on biotech. and the stock of the day, a massive move lower in nike. the footwear maker down 11% right now, just kind of hovering near the lowest levels of the session. it was a mixed report. earnings came out better than expected. revenues were a slight miss, but it cut its revenue forecast for the year. so nike shares down 11% right now. a bit of a drag, but the dow still in positive territory. back over to you. >> dom, thanks. >>> the fed's favorite inflation gauge showing prices rose 3.2% in november, just below what economists expected. headline pce was up 2.6% from a year ago. as inflation fears ease, my next guest says three rate cuts ahead next year. welcome, tom. and also with me, cnbc's steve liesman. so sluggish growth you expect in 2024? >> we do. this i think is the thing we need to sort of start to get our heads around a little bit. yeah, you probably avoid a recession. again, it will be close and there are some risks that are worth talking about. but if ou

united health, amgen, crowdstrike, unp, domino's next. >> my ambition when i was starting out, survivale the word ambition. >> ambition is passion. >> it's a key ingredient of greatness. >> to me it is undaunted by the impossible. >> i'm ambitious for the nation. i'm ambitious for its people. i'm ambitious for my people. >> my ambition has been to seek the truth. >> to learn as much as i possibly could. >> to make an impact. >> i believe in dreaming big. >> my ambition -- >> ambition, it's got america written all over it. >> ambition really is the foundation of capitalism. >> i wanted to do great things in this country. my ambition is to do really well in business and to take those profits and recycle back into society to make the world a better place. >> everything can be a reality. >> i see ambition everywhere. >> human ambition is what drives the world. you know when you have those moments? that time to reflect. to be like wow! what did i do to get here? (tense music) right. work. you worked hard and it's time for a bank that'll work hard for you. everbank performance savings is buil

big board, swing the camera over, there you have it up 67 points, 36358, dow winners, nike, walgreen, amgent, cigna, best buy, broad, the nasdaq winners, a top by, global boundaries inc., broad, kla, micron, old dominion, those exciting on the nasdaq, no big tech. coming up "saturday night live" any backlash for the focusing on republican congresswoman elise stefanik and the testimony of the college present. there is a brief clip, watch this. >> i'm going to start screaming question that these women like i'm billy eichinger. yay or nay. >> that is so wrong media guy joe concha reacts to it the weight loss drug ozempic could help people control their drinking, doctor siegel is here on that. the white house refuses to take responsibility for inflation. instead accusing companies a price gouging economist stephen moore on that next. ♪ (adventurous music) ♪ ♪ ♪ be ready for any market with a liquid etf. get in and out with dia. stuart: 12 minutes worth of business and we turn the market around the top 27, fractional gain for the s&p, the nasdaq 1025, the federal government hiring a near record

amgen, chevron, dow, 3m m and cisco systems all the win ors in the dow, and if we could look at the samers, newmont mining, gold corp., moderna, albemarle, zion's bank corp. all in the green for the s&p. and the nasdaq winners, moderna, enphase, dollar tree and american electric power. >>> coming up, celebrity chef andrew gruel is fed up with the crime plaguing california. he's going to keep his remaining locations open, but he now refuses to create any if new spots in the golden state because of the crime. he is here. of. >>> and christmas may be canceled in bethlehem, but that's not stopping the holy land from finding hope this holy season. theologian jonathan morris, we love jonathan, he takes that on, and he's with us live. >>> and just in time for holiday gatherings, a new, highly contagious covid strain is actually driving cases up. does this mean if we're all getting sicker quicker? dr. marc siegel is in next. ♪ christmas, pretty lights on the tree -- ♪ christmas, i'm watching them shine. ♪ christmas, you should be here with me. ♪ christmas, baby, please come home ♪ you know what'

intel, caterpillar leading the way with, amgen and salesforce at the bottom end of the dow.-- 115 points on the dow, as you can see. >>> here's a question for you, can improving your sense of smell actually help redouse your risk of dementia? -- reduce your risk of dewhen shah? a new study suggests just that. a doctor will tell us if this study passes, dare i say, the smell test. next. ♪ ♪ they're waiting for you. hey, do you have a second? they're all expecting more. more efficiency. more benefits. more growth. when you realize you can give your people everything, and more. thank you very much. [applause] ask, "now what?" here's what. you go with prudential to protect, empower and grow. with everything you need to deliver, you guessed it... more. one more thing... who's your rock? learn more at prudential.com - [speaker] at first, just leaving the house was hard. - [speaker] but wounded warrior project helps you realize it's possible to get out there - [speaker] to feel sense of camaraderie again. - [speaker] to find the tools to live life better. - [narrator] through gener

we've got intel, salesforce, am-ex wall greens goods alliance, amgen and 3m.ming right back with a story we feel you really need to see. stay tuned. ♪ snuck observing investors choose assets to balance risk and reward. with one element securing portfolios, time after time. gold. agile and liquid. a proven protector. an ever-evolving enabler of bold decisions. an asset more relevant than ever before. gold. your strategic advantage. you can't buy great conversations or moments that matter, but you can invest in them. at t. rowe price our strategic investing approach can help you build the future you imagine. t. rowe price, invest with confidence. reliq health is a digital health company targeting the $100 billion virtual care market. reliq is rapidly growing with customers that include several of the largest and most highly rated health care organizations across the nation. reliq health technologies. hi, i'm kevin, and i've lost 152 pounds on golo. (uplifting music) my biggest concern when i started golo was food. i'm a big guy and, shockingly, i like to eat. i

walgreens is up, nike, salesforce.com, amgen and caterpillar. all right.let me see, we saw uber coming on the s&p yesterday -- lauren: yeah. first day listed on the s&p 500, yep. david: enphase energy, solar 'em tech, first solar and albemarle, corporations all doing well. and the nasdaq winners, if we could switch to that, we have enphase again, lucid group, tradedesk, sirius is up. whoops, it just fell off. paypal and -- lauren: a lot of green stocks are higher today. also the dow and the nasdaq are up nine days in a row, so the gains are small, but the longevity is long. david: i would not look at my 401(k) right now just because i get other hi anxious, and then t goes up is bound to come down -- lauren: well, yields are coming down, there you go. david: that's right. yields are coming down nicely although right now it's just a small, it's almost equal. the 10-year yield has come down .1 basis e points to 3.932. -- 3.92. gold, there's an inverse relationship between the value of the dollar and the value of gold, gold is going up at the dollar comes down

i think ibb, and i look at the amgens and the biogens, and that is a safer place to be on both the balanceetter earnings profile. >> we're talking about $105 billion company in bristol meyers, we'll call it megacap. $14 billion takeover target. and that's where these stocks are doubling. i wonder if the charts, are you seeing anything there that says i it is going to be the ibb types or -- >> and you both are raising that important point. the way to look at it is xbi, because it's equal weight. it was the single-most destroyed from the '21 peak to the lows. but it's moved up 40% from the low. matching the home builders, because it's a small cap phenomenon, but it's also, well, if rates are going to be calming down, we can play with multiples more. but either way, i think one once, and you can see it on the chart, a triple bottom, it's beautiful. the move above the trend line. the question is, do you play this momentum? versus kre? i think this has legs, where something like kre, not so much. >> you would rather smid-cap bio tech versus banks? >> hard to put any big dreams on banks. >> all

amgen we like. it's taking up a lot of the air and everyone from every sector sort of gop wants.ly runway powerful drug for americans. that is great to prove the power of biotech and pharma and drug prices. out of sanders this week. i think it's -- because it's drawing money to the sector, proving stocks can work, you can have successful platforms. i think that's going to obviously drive a huge amount of cash, becky, towards other companies which are going to be targets, as beginning of this conversation. that's good for biotech. it's a good thing and we need more of that. >> we can do other things besides just obesity. so much promise in the medical world. michael, thank you for joining us. happy holidays if we don't see you sooner. >> thank you. >>> meantime, costco shares. look at this. on the move this morning. the wholesale club real tailor retailor -- retame er same-store sales and special cap end of $15 a share payable in january, becky. talking about membership clubs top of the show and here we are. >> here we are. yeah. $14 gain for that stock. >>> up next, a can't-miss

we'll get to adobe, amgen, pfer, pepsi, chewyn a minute loving this pay bump in our allowance.onder where mom and dad got the extra money? maybe they won the lottery? maybe they inherited a fortune? maybe buried treasure? maybe it fell off a truck? maybe they heard that xfinity customers can save hundreds when they buy one unlimted line and get one free. now i can buy that electric scooter! i'm starting a private-equity fund that specializes in midcap. you do you. visit xfinitymobile.com today. >>> cybersecurity is in the spotlight. our parent company comcast disclosing suspicious activity during a routine cybersecurity exercise on october 25th and said it has notified federal law enforcement and started an investigation. they add it was due to a sit trick software vnerability and been resolved.elated risk has last night on "mad money," the ceo of palo alto >> i think it's just beginning i think we'll see more and more of this activity come 2024 you'll see more and more conversation around it like i said, it's still the most profitable business with the least amount of convicti

i amgen fer casarian and i work here at san francisco international airport. the idea for therapy dogs got started the day after 9/11. an employee brought his therapy dog to work after 9/11 and he was able to see how his dog was able to relieve passenger's jitter. when we first launched the program back in 2013, our main goal was to destress our passengers however what we quickly found is that our animals were helping us find a way to connect with our pang. passengers. we find there are a lot of people traveling through the airport who are missing their pets and who are on their road a lot and can't have pets and we have come in contact with a lot of people recently who have lost pet. >> i love the wag brigade. >> one of my favorite parts is walking into the terminals and seeing everybody look up from their device, today everybody is interacting on their cell phone or laptop and we can walk into the terminal with a dog or a pig and people start to interact with each other again and it's on a different level. more of an emotional level. >> i just got off an 11.

. >> amgen is a dow. >> yes. >> boots alliance.got to be on your toes, andrew. >> i am on my toes. you have to be on your toes if you are trying to get airfare these days. we want to talk travel. a lot of people are headed to do that according to kayak. flights and hotels and car rentals are cooling off for the new year. joining us is the co-founder of kayak owned by booking holdings. steve, i think you know this. when i travel, i'm a kayak guy. it is an interface for me. thank you for that. >> love it. love it. thanks, andrew. >> it is always the case. obviously, once you get into one of these things, you stick with it. let me ask about pricing. the good news for the customer, things are cooling down. when is the cooldown happening? are people trying to make last-minute plans where you get good fares? what are you looking at here? >> you are asking these questions on the second busiest travel day of the year. >> that is why i thought there would be no good prices. >> prices have come down. they came down from the elevated level. i

i amgen fer casarian and i work here at san francisco international airport.the idea for therapy dogs got started the day after 9/11. an employee brought his therapy dog to work after 9/11 and he was able to see how his dog was able to relieve passenger's jitter. when we first launched the program back in 2013, our main goal was to destress our passengers however what we quickly found is that our animals were helping us find a way to connect with our pang. passengers. we find there are a lot of people traveling through the airport who are missing their pets and who are on their road a lot and can't have pets and we have come in contact with a lot of people recently who have lost pet. >> i love the wag brigade. >> one of my favorite parts is walking into the terminals and seeing everybody look up from their device, today everybody is interacting on their cell phone or laptop and we can walk into the terminal with a dog or a pig and people start to interact with each other again and it's on a different level. more of an emotional level. >> i just got off an 11.5

amgen, 275. s&p 500 winners, vertex, take two interactive, albemarle, emerson electric.ers, show me a big name tech stock. they're not there. but airbnb is up there, astrazeneca, marvell technology. where's the 10-year? it is down this morning, 4.15%. that does help big tech and the nasdaq. the price of gold, below $2,000 an ounce, $1998. check bitcoin, 41 and change last time we checked it, 41,3 right now. oil, well below $70 a barrel, you're all the way down to 68.8ing 6. nat gas? up, down or sideways? show me, please. it is down this morning a tiny fraction. >>> i'm intrigued at the price of gasoline, it chemos on coming down -- it keeps on coming down. you're at $3.12 for the national average, and diesel down as well, $4.07. >>> florida attorney general ashley moody fed up with shoplifters. she launched a statewide task force to combat organized retail crime. she's going to tell us what she's going to do. >>> lebron james taking heat for what he was doing at his son's basketball game. critics say he has no respect for americaful we'll tell you what he did. >>> the co